Latest news about Ortin Global
Ortin Global
18.11
+1.64(+9.96%)
Company Performance:
View Company Insights1D+9.96%
1M+18.91%
6M+24.98%
1Y+62.42%
5Y-35.09%
More news about Ortin Global
26Feb 26
Ortin Global Ltd: Suresh Gadala Group Crosses 5% Shareholding Threshold with Fresh Acquisition
Suresh Gadala and his family members have acquired 31,640 equity shares of Ortin Global Ltd through open market purchases on February 23, 2026, increasing their combined shareholding from 4.91% to 5.30%. This acquisition triggered mandatory disclosure requirements under SEBI regulations as their holding crossed the 5% threshold. The acquirer group, which includes Suresh Gadala's wife and son, does not belong to the company's promoter group and holds only equity shares with no encumbrances or convertible securities.
18Feb 26
Ortin Global Limited: Parveen Satija Announces Open Offer for 26% Stake at ₹14.65 Per Share
Mr. Parveen Satija has announced an open offer to acquire 21,14,162 equity shares (26% voting capital) of Ortin Global Limited at ₹14.65 per share, with total consideration of ₹3,09,72,473.30. The offer follows a Share Purchase Agreement with promoter sellers for 1,00,300 shares (1.23% stake). The acquirer has established financial arrangements including an escrow deposit of ₹80,52,850 with Axis Bank Limited and will implement the offer through BSE's acquisition window mechanism from April 10-24, 2026.
15Feb 26
Ortin Global Limited Announces Q3 FY26 Financial Results for Quarter Ended December 31, 2025
Ortin Global Limited announced its Q3 FY26 unaudited financial results for the quarter ended December 31, 2025, following a board meeting held on February 14, 2026. The results were approved in compliance with SEBI regulations and underwent independent review by Mathesh & Ramana Chartered Accountants. The company, formerly known as Ortin Laboratories Limited, maintains its registered office in Hyderabad and continues to ensure regulatory compliance in its financial reporting.
14Feb 26
Ortin Global Limited: Parveen Satija Issues Corrigendum to Open Offer Announcement
Mr. Parveen Satija has issued a corrigendum to his February 10, 2026 public announcement regarding the open offer for Ortin Global Limited. The corrigendum clarifies regulatory compliance aspects under SEBI SAST Regulations while maintaining all original offer terms including the ₹14.65 per share price for acquiring 26% stake. All fundamental parameters of the open offer remain unchanged.
05Feb 26
Ortin Global Limited Schedules Board Meeting for February 14, 2026 to Review Q3FY26 Financial Results
Ortin Global Limited has scheduled a board meeting for February 14, 2026, to consider unaudited financial results for the quarter and nine months ended December 31, 2025. The meeting will be held at the company's registered office in Hyderabad in compliance with SEBI regulations. The company, formerly known as Ortin Laboratories Limited, has notified both BSE and NSE about this meeting as required under listing obligations.
02Aug 25
Ortin Global Limited Schedules EGM for Board Appointments and Remuneration Changes
Ortin Global, formerly Ortin Laboratories, has scheduled an EGM for August 25, 2025, to appoint new directors and make leadership changes. The company plans to appoint Mr. Sarang Balbhimrao Patodekar as Chairperson and Independent Director, along with Mr. Ajay Vishwakarma and Ms. Mounika Pammi as Independent Directors. Mr. Prashant Prakash Sawant and Mrs. Prakruti Prashant Sawant are proposed as Whole-time Directors with a monthly remuneration of Rs. 55,000 each. The pharmaceutical company reported a turnover of Rs. 602.03 lakhs for FY 2024-25 with a net loss of Rs. 9.36 lakhs. Remote e-voting will be available from August 22-24, 2025, with August 18, 2025, as the cut-off date for voting eligibility.
Industry Peers
Sun Pharmaceutical
Divis Laboratories
Torrent Pharmaceuticals
Cipla
Zydus Life Science
Dr Reddys Laboratories
Lupin
Mankind Pharma
Aurobindo Pharma
Laurus Labs
1,782.20
(+0.12%)
6,623.00
(+0.40%)
4,420.90
(+1.87%)
1,401.30
(+0.19%)
1,089.00
(+0.41%)
1,278.20
(+0.84%)
2,267.70
(+0.80%)
2,336.10
(-0.72%)
1,462.30
(-0.09%)
1,446.80
(+1.37%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
